Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
FC001
- Development stage
- Unknown
- Lead developer
- ForCast Orthopedics
- Modality
- Small Molecules
- Administration
- Intraarticular, Oral, Intravenous
01
Overview
FC001 refers to two distinct investigational products. (1) Developed by ForCast Orthopedics, FC001 is a targeted antibiotic therapy for the treatment of periprosthetic joint infection (PJI). It utilizes a proprietary Wearable Intra-Articular Infusion System (WIIS) to deliver vancomycin directly into the infected joint, targeting biofilm-resistant gram-positive bacteria. This program has received FDA Orphan Drug and Qualified Infectious Disease Product (QIDP) designations. (2) Developed by FerroptoCure KK, FC-001 (also known as FC001) is a small molecule inhibitor of the cystine/glutamate transporter SLC7A11 (xCT). It is designed to induce ferroptosis specifically in cancer cells and is currently in Phase 1 development for triple-negative breast cancer (TNBC) and other solid tumors.
- Other names
- WIIS + vancomycin
02
Targets
SLC7A11 (Cystine-Glutamate Antiporter)D-Ala-D-Ala (D-Ala-D-Ala terminus)
Beyond the preview
Go deeper on FC001.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FC001.